Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
Amemiya
H
H
National Children's Medical Research Center, Tokyo, Japan.
Taguchi
Y
Y
Fukao
K
K
Isono
K
K
Omoto
R
R
Ota
K
K
Kosaki
M
M
Takagi
H
H
Oka
T
T
Sonoda
T
T
D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D013997:Time Factors
D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus